Browsing: Homepage Slider
0
Deactivating microglia reduces tau-linked brain damage in mice, study reveals
A recently published study has indicated that eliminating microglia could significantly reduce tau-linked brain damage in mice, providing a path for novel treatments.
0
Signs of dementia may be detected earlier in women with new diagnostic criteria
Researchers have discovered that more women and less men are diagnosed with amnestic mild cognitive impairment when sex-specific scores are used.
0
World Mental Health Day: facts, figures and the flaws of academia
In this World Mental Health Day editorial, Dani Beck provides us with an overview of what the day entails and what general knowledge people should be aware of, as well as a focus on mental health issues in the realm of academia.
0
Neuroprosthetic exoskeleton allows tetraplegic patient to utilize his limbs
Wireless brain–machine interface technology has been utilized to design an exoskeleton for helping a tetraplegic patient move his limbs.
0
Traumatic CNS injury and the inflammatory stem cell niche: an interview with Aileen Anderson
At the 21st Spinal Research Annual Network Meeting, we had the pleasure of speaking with Aileen Anderson about her talk on ‘Traumatic CNS injury and the inflammatory stem cell niche’, including the obstacles involved with tissue regeneration following injury and the how this could be overcome.
0
Ask the Experts: The future of dementia research
In this written ‘Ask the Experts’ column, we bring together leaders from our partnered organizations (Alzheimer’s Research UK, Alzheimer’s Society and the UK DRI) to discuss what the future of dementia research might hold.
0
A first-in-human, gene-silencing treatment for Alzheimer’s disease with Catherine Mummery
Genetic therapies represent a remarkable avenue for potentially slowing and preventing neurodegenerative diseases. This includes a first-in-human, gene-silencing treatment for Alzheimer’s disease. Find out more on this from Catherine Mummery.
0
Translating blood biomarkers into the clinic for neurodegenerative diseases with Henrik Zetterberg
In this video, we spoke with Henrik Zetterberg to find out how challenges with replication, reproducibility and specificity could be addressed in the field.
